Global Liquid Biopsy Market Expanding at 28.9% CAGR During 2016-2024

New York, USA, 2018-Dec-07 — /EPR Network/ —  According to Goldstein Research,  Liquid Biopsy Market is anticipated to grow at 28.9% CAGR over the forecast period 2016-2024, to reach a market size of USD 3.85 billion by the end of forecast period. A number of factors such as soaring incidences of cancer, rising awareness about biopsy in the target population and increasing government initiatives to spread awareness tends to propel the growth of liquid biopsy market.

The expansion of Point of Care Diagnostics Market is driving the growth opportunities for liquid biopsy market. Moreover, the expansion of global Cancer Biosimilars Market is witnessed to be influencing the growth of liquid biopsy market in terms of further treatment of cancer. Furthermore, the technological advancement in Cancer Biomarker Market has led to huge application of liquid biopsy for the early detection of cancer.

Browse Full Report:

Market Segmentation

Based on our in-depth analysis of Global Liquid Biopsy Market, itcan be segmented as follows:

On the basis of product

  • Reagents
  • Instruments

On the basis of cancer type

  • Lung cancer
  • Breast cancer
  • Liver cancer
  • Prostate cancer
  • Others

On the basis of technology

  • Circulating tumor cells
  • Circulating endothelial cells
  • Cell free circulating DNA

On the basis of end user

  • Reference laboratories
  • Hospital/physician laboratories
  • Academic and research centers

By Region

  • North America Liquid Biopsy Market Analysis, 2016-2024
  • Europe Liquid Biopsy Market Analysis, 2016-2024
  • Middle East And Africa Liquid Biopsy Market Analysis, 2016-2024
  • Latin America Liquid Biopsy Market Analysis, 2016-2024
  • Asia Pacific Liquid Biopsy Market Analysis, 2016-2024


“Global Liquid Biopsy Market Outlook 2024” includes comprehensive overview of the global liquid biopsy market. On the basis of our in-depth analysis, market can be segmented in terms of market segmentation by product, cancer type, technology, end user and geography.

Key players mentioned in the report are:NeoGenomics, Biocartis, Guardant Health, Trovagene, Pathway Genomics, Biocept inc., QIAGEN, Cambridge Epigenetix, Inivata, Nodexus, Genomic Expression, LARIAT BIOSCIENCES, INC., GPB SCIENTIFIC, LLC, Bert Vogelstein, Johns Hopkins, Elypta, Cambridge Oncometrix Limited, Epigenomics AG, Genetron Health Technologies Inc., Stem Sel, Vortex Biosciences, Cynvenio Biosystems, Mursla, NetScientific, Clearbridge BioMedics Pte Ltd, OncoCyte Corporation, Circulogene, CYTOFIND DIAGNOSTICS BV, SIMFO GmbH, Liquid Biopsy,  Illumina,etc.

Key Highlights in Global Liquid Biopsy Market Report:

  • The global liquid biopsy market report highlights the competitive outlook of major global players, their business strategies, financial analysis, product portfolio, revenue distribution, R&D activities and investments. The competitive analysis also analyses the mergers, acquisitions and partnership scenario in the industry.
  • The comprehensive analysis of liquid biopsy market report is drafted as per the clients to help them in assessing their business strategies in the competitive environment.
  • Global liquid biopsy market report encompasses the analysis of new opportunities emerging in the market,major factors driving the growth of market, and the factors posing threats & challenges to the market.
  • The liquid biopsy market outlook also comprises the market analysis based on market dynamics, risk factors, USP analysis, SWOT analysis, BPS Analysis & market attractiveness.
  • Further the liquid biopsy market report includes the expert analysis and remarks showcasing the complete overview of the market based on intensive analysis of political, economic, social, technological, environmental & legal factors of each region covered in the market.

Matched content

Editor’s pick